Search results for: 'dots 2 drug grid coat'

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

20 Feb 2025  |  Global  |  Technology Research

Vehicle-to-Grid in EV Charging Infrastructure, Recent Technological Developments and Growth Opportunities, 2024–2030

Exploring Vehicle-to-Grid Technology Integration, Challenges, and Opportunities

Infographics

×

The traditionally distinct transport and power sectors are increasingly converging through the common element of electric power. As electric vehicle (EV) numbers grow and renewable energy sources gain market share, their integration into the conventional power grid is becoming a technical necessity and a strategic opportunity. Bidirectional energy ...

05 Sep 2022  |  Global  |  Technology Research

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

Infographics

×

Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...

This edition of the Advanced Coating & Surface Technology Opportunity Engine profiles significant advances in advanced coatings and surface treatments for various industrial applications. The featured innovations include Next-Generation Low-Emissivity Coatings for Lightweight Transparent Glazing, Plant-Based Edible Film As a Substitute for Plastic ...

This edition of the Advanced Coating & Surface Technology Opportunity Engine profiles significant advances in advanced coatings and surface treatments for various industrial applications. The featured innovations include Smart Coatings for Real-Time Surface Sensing, Antifouling Coatings for Commercial Vessel Hull Performance Management, Advanced Hy...

The ongoing global and regional efforts to decentralize and decarbonize the energy industry have resulted in an increasingly digitized network. This will be a more interconnected, intelligent, and responsive energy infrastructure that continuously generates substantial amounts of data. However, the industry historically lacks innovative technologie...